LMD LED Medical Diagnostics Inc

LED Medical Diagnostics Inc. (TSX VENTURE:LMD) announced today that its VELscope
Vx enhanced early detection system has just been approved for use by AppleWhite
Dental Partners. The VELscope Vx is exclusively distributed in the U.S. and
Canada by Henry Schein, Inc. (NASDAQ:HSIC).


"We are very pleased that the VELscope Vx has received the approval of yet
another demanding and respected group dental practice," said Peter Whitehead,
founder and CEO of LED Dental and its parent company, LED Medical Diagnostics
Inc. (TSX VENTURE:LMD). "AppleWhite Dental Partners takes great pains to select
only the finest technologies for its practices and their patients, and it is
very gratifying to have them approve our VELscope Vx."


LED Dental introduced the first generation of VELscope's fluorescence
visualization technology about five years ago in response to the fact that oral
cancer was one of the few types of cancer that had not experienced a significant
decline in mortality over the previous several decades. VELscope technology
gives dental practitioners an adjunctive visualization aid that should be used
together with, and after, a traditional intra-and extra-oral head and neck exam
in hopes of detecting oral lesions that might otherwise have been overlooked.


"Our mission is to create a partnership with our dentists that allow them to
practice innovative dentistry and provide an outstanding patient experience,"
said Dr. Thomas McCoy, CEO of AppleWhite Dental Partners. "Adding the
state-of-the-art VELscope Vx enhances the ability of our dentists to discover
oral cancer and other oral disease in early stages, and in a way that is
completely non-invasive for their patients."


The National Cancer Institute's SEER website indicates that oral cancer is most
often detected in late stages, when the 5-year survival rate is less than 50%.
When detected early, however, the 5-year survival rate leaps to approximately
82%. Because the VELscope Vx is so sensitive to oral mucosal changes, it can
help increase the odds that cancer will be detected in early and even
precancerous stages.


"In fact," said Mr. Whitehead, "VELscope technology increases the likelihood of
detecting all types of oral disease at earlier stages, which is good news for
the patient as well as the practice."


Since the launch of the first generation model, over 10,000 VELscope devices
have been purchased by dental practices globally. It is estimated that these
devices have been used to conduct over 10 million oral cancer exams during that
time, easily making the VELscope the world's number one adjunctive oral cancer
screening technology.


The VELscope Vx, the latest generation of the technology, is the first to offer
cordless convenience as well as an optional digital camera and customized
bracket that make it easy for dentists to photo-document suspicious lesions that
are referred to specialists for surgical biopsy.


"We have considered all available options," said Dr. Mark Mosier, Director of
Dentistry for AppleWhite Dental Partners, "and we are confident that the
VELscope Vx offers the most effective, most convenient and most economical
solution for both our practices and their patients."


AppleWhite Dental Partners provides an array of services to 17 participating
dental practices in Iowa, Illinois and Minnesota. By providing business support,
professional mentoring, and administrative and consulting services, AppleWhite
Dental Partners allows its participating dentists to devote their time to caring
for patients, continuing education, and honing clinical skill.


About LED Medical Diagnostics Inc.

Founded in 2003, LED Medical Diagnostics Inc., (TSX VENTURE:LMD) is a
fast-growing public company offering effective early-stage oral cancer detection
technologies in 23 countries worldwide. The company makes the VELscope Vx, a
powerful tool for detecting early stage oral cancer that is approved by the FDA,
Health Canada and European regulators. The company is headquartered in Burnaby
British Columbia, Canada. For more information please call +1 (604) 434-4614, or
visit www.VELscope.com.


About the VELscope Vx

The VELscope Vx is a powerful FDA-approved tool used to screen for oral cancer.
It saves lives by helping detect early stage oral cancer and pre-cancer and
other abnormalities in the mouth such as viral, fungal and bacterial infections.
The VELscope Vx is exclusively distributed worldwide through a partnership with
Henry Schein, the world's largest dental distribution company. For more
information please call +1 (604) 434-4614, or visit www.VELscope.com.

LED Medical Diagnostics (TSXV:LMD)
Historical Stock Chart
From Jun 2024 to Jul 2024

LED Medical Diagnostics (TSXV:LMD)
Historical Stock Chart
From Jul 2023 to Jul 2024